View Older Stories

Jan 29, 2026 12:17PM Freedom Capital Markets Upgrades Abbott Labs (ABT) to Buy

Jan 29, 2026 04:51AM Increasing unusual put option volume: KDP HYMC GOSS FE TSCO HUM LRN APH AQST ABT IBRX

Jan 28, 2026 05:06AM Increasing unusual put option volume: KDP VFC GOSS UL AR CPNG EQNR SYY JETS UUP XRX ABT NOC GLW

Jan 23, 2026 10:04AM UBS Reiterates Buy Rating on Abbott Labs (ABT), Says Sales Growth to Drive Shares

Jan 23, 2026 08:26AM Abbott Labs (ABT) PT Lowered to $125 at Bernstein SocGen Group

Jan 23, 2026 08:04AM Abbott Labs (ABT) PT Lowered to $137 at TD Cowen

Jan 23, 2026 07:33AM Benchmark Reiterates Buy Rating on Abbott Labs (ABT): Annual Estimates Unchanged

Jan 23, 2026 07:19AM Abbott Labs (ABT) PT Lowered at RBC Capital Amid 'Challenging Year-End'

Jan 23, 2026 07:06AM Abbott Labs (ABT) PT Lowered to $135 at Piper Sandler After a 'Disappointing Q4'

Jan 23, 2026 06:02AM Abbott Labs (ABT) PT Lowered to $132 at Oppenheimer

Jan 23, 2026 05:52AM Abbott Labs (ABT) PT Lowered to $122 at Wells Fargo

Jan 23, 2026 05:08AM Abbott Labs (ABT) PT Lowered to $130 at Raymond James

Jan 23, 2026 04:59AM Abbott Labs (ABT) PT Lowered to $145 at Jefferies

Jan 22, 2026 10:45AM Increasing unusual put option volume: IBRX HSBC CRVS KBE HWM HBAN NUAI SEI COPX PSX ABT

Jan 22, 2026 07:32AM Abbott (ABT) Reports In-Line Q4 EPS; offers guidance

Jan 21, 2026 10:27AM Abbott (ABT) call put ratio 1 call to 1.7 puts into quarter results

Jan 20, 2026 11:05AM Abbott (ABT) call put ratio 1 call to 1 put into quarter results

Jan 20, 2026 09:16AM TD Cowen on Abbott Labs (ABT): 'We Expect A Good Q4 Report'

Jan 9, 2026 07:33AM Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'

Jan 8, 2026 11:21AM Abbott (ABT) call put ratio 2 calls to 1 put into the annual J.P. Morgan Healthcare Conference

Jan 5, 2026 09:06AM Abbott launches AI-powered meal guidance feature for diabetes app

Dec 30, 2025 10:30AM Increasing unusual call option volume: FEZ ZSL TRIP UA NAVN SLS LCTX AXTI COMP RARE GGLL ABT

Dec 22, 2025 08:41AM BTIG Reiterates Buy Rating on Abbott Labs (ABT)

Dec 15, 2025 07:42AM Bernstein Shares Takeaways From the 5th Annual Diabetes Disruptor Conference

Dec 12, 2025 10:29AM Abbott (ABT) Raises Quarterly Dividend 6.8% to $0.63; 2% Yield

Nov 21, 2025 09:21AM Benchmark Reiterates Buy Rating on Abbott Labs (ABT) Following Deal to Acquire Exact Sciences (EXAS)

Nov 21, 2025 07:45AM UBS Reiterates Buy Rating on Abbott Labs (ABT): Modelling ~6% Dx growth TOT in 2026

Nov 20, 2025 07:44AM Exact Sciences stock jumps after Abbott confirms acquisition

Nov 19, 2025 04:39PM BTIG Reiterates Exact Sciences (EXAS) at Buy, 'tie up between ABT and EXAS makes sense'

Nov 19, 2025 04:00PM Wolfe Research Reiterates Peerperform Rating on Abbott Labs (ABT)

Nov 19, 2025 01:49PM Exact Sciences (EXAS) resumes trading, up 28%

Nov 19, 2025 01:42PM Abbott reportedly nearing deal for Exact Sciences

Oct 17, 2025 04:00PM Make sure you own this high-quality MedTech stock: RBC

Oct 17, 2025 09:37AM Abbott Labs (ABT) PT Raised to $158 at UBS

Oct 16, 2025 09:30AM UBS Reiterates Buy Rating on Abbott Labs (ABT), Highlights Buying Opportunity

Oct 16, 2025 08:31AM Benchmark Reiterates Buy Rating on Abbott Labs (ABT), Following In-Line Q3 Results

Oct 16, 2025 06:17AM RBC Capital Reiterates Outperform Rating on Abbott Labs (ABT), 'dips create opportunity'

Oct 16, 2025 06:08AM Abbott Labs (ABT) PT Raised to $150 at Bernstein SocGen Group

Oct 16, 2025 05:02AM Abbott Labs (ABT) PT Raised to $146 at Wells Fargo

Oct 16, 2025 04:59AM Abbott Labs (ABT) PT Raised to $146 at Jefferies

Oct 15, 2025 07:32AM Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS Guidance

Oct 15, 2025 05:08AM Abbott (ABT) October 133 straddle priced into quarter results

Oct 15, 2025 05:00AM Raymond James expects modest upside for this MedTech stock in Q3 results

Oct 14, 2025 11:00AM Abbott (NYSE: ABT) call put ratio 1.2 calls to 1 put into quarter results

Oct 10, 2025 06:36AM Benchmark Starts Abbott Labs (ABT) at Buy

Oct 8, 2025 09:20AM Abbott Labs (ABT) 'One of Our Highest Conviction Calls' - UBS

Oct 5, 2025 08:00PM UBS on why it's still not ready to push the buy button on pharma stocks

Oct 1, 2025 09:09AM Here are the October additions to Goldman's 'U.S. Conviction List - Directors' Cut

Oct 1, 2025 05:20AM Goldman Updates US Monthly Directors' Cut Conviction List, Fours Adds and Three Removals

Sep 25, 2025 07:31AM Needham: 'we believe that the Section 232 investigation creates a new overhang for the already beleaguered medical device sector'

View Older Stories